Long-Term High Flow Nasal Cannula Management
Patient Selection and Management
- The European Respiratory Society suggests considering long-term HFNC for patients with chronic respiratory diseases who have persistent respiratory insufficiency despite optimal medical management, taking into account patient characteristics including comorbidities, severity of respiratory failure, and ability to manage home respiratory equipment 1, 2
- Flow rates for long-term home use typically range up to 60 L/min for adults, with temperature maintained at 37°C and 100% relative humidity, as recommended by medical guidelines 3
- FiO2 should be titrated to maintain target oxygenation, with the goal of achieving PaO2 70-90 mmHg or SpO2 92-97% for most patients, or 88-92% for those at risk of hypercapnia, according to clinical guidelines 3
Monitoring and Follow-Up
- Patients on long-term HFNC require continuous or frequent monitoring of oxygen saturation to ensure adequate oxygenation on prescribed settings, as well as regular assessment of respiratory rate, work of breathing, and dyspnea symptoms to evaluate ongoing effectiveness 4, 3, 5
- The European Respiratory Society recommends obtaining periodic arterial blood gases or pulse oximetry data to confirm adequate gas exchange on current HFNC settings 5
Weaning and Special Considerations
- Patients should demonstrate sustained clinical improvement with stable respiratory rate, minimal work of breathing, and oxygen saturation consistently at target levels before attempting to wean from long-term HFNC, as suggested by medical guidelines 4
- The weaning process should involve gradual decreases in flow rate and FiO2, with close monitoring of the patient's condition, according to clinical recommendations 4
- Immunocompromised patients may benefit from long-term HFNC and require more conservative weaning criteria and closer monitoring, as recommended by the European Respiratory Society 7, 5, 4